Institute of Immunity and Transplantation
A partnership to bring together world-leading research and clinical trials in a multi-million pound purpose-designed centre at the Royal Free Hospital in Hampstead. The Institute’s vision is to become the leading European hub for experimental medicine in its field, transferring novel research concepts in immunity and transplantation into new diagnostic tools and treatments.
Experimental platforms in:
- Transplantation and tissue engineering
- Cell therapy
- Gene therapy
Novel treatments for patients with:
- Chronic infection
- Inherited diseases
Dr John James will be speaking on Exploring the mechanism of T-cell receptor-mediated decision making: how does a receptor count to ten? as part of the Institute's seminar series, on 24 April. More...
Dr Klaus Okkenhaug has a long-standing interest in the roles of phosphoinositide 3-kinase (PI3K) enzyme isoforms in immune activation, particularly in T and B cells. His research group is based at the Laboratory of Lymphocyte Signalling and Development at the Babraham Institute and he currently holds a Wellcome Trust New Investigator Award. More...
Professor Andrew Macdonald has focused his research career in the
States and in Edinburgh on understanding role of Dendritic cells (DC) in
driving Th2 responses, in particular following parasite infection.
Page last modified on 06 feb 14 13:52